This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

JOSEPH B. PETERSON, M.D.; EUGENE M. FARBER, M.D.; GEORGE P. FULTON, Ph.D.

Arch Dermatol. 1960;82(4):495-500.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The nicotinate rubefacients have recently attracted the interest of the dermatologist. The application of the tetrahydrofurfuryl ester of nicotinic acid to the skin of patients with rheumatic fever,^1,2 systemic lupus erythematosus,³ nontuberculous forms of pneumonia,⁴ atopic dermatitis,⁵ and certain other disorders has resulted in altered cutaneous reactions. An interest in the mode of action of such preparations and in the significance of the vascular responses they produce has thus been fostered. Therapeutically, dermatologists have recently employed such preparations in the treatment of alopecia areata^6,7 and localized scleroderma.⁷

These and other interesting studies stimulated a recent evaluation of the efficacy of certain attested rubefacient preparations.⁸ This study disclosed that the rubefacient activity of equal strength preparations of ethyl nicotinate, of methyl nicotinate, and of the tetrahydrofurfuryl ester of nicotinic acid was for all intents and purposes equal. Since this work we have employed selected . . . [Full Text PDF of this Article]

Author Affiliations
Palo Alto, Calif.; Boston

From the Division of Dermatology, Stanford University School of Medicine (Dr. Peterson, Dr. Farber); Visiting Professor of Biology from Boston University (Dr. Fulton).

Footnotes
Submitted for publication Feb. 4, 1960.

Supported by U.S.P.H.S. Grant #H-3833 Herbert L. Harland Dermopathology Fund.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?